Status:
NOT_YET_RECRUITING
Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Antibody Mediated Rejection After Kidney Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Humoral rejection of kidney transplants is responsible for a large number of kidney graft losses in a context of increasing shortage. Although it has been established that it is largely mediated by t...
Eligibility Criteria
Inclusion
- Adult kidney transplant recipients admitted for biopsy or graft removal in the participating nephrology departments.
- Patient participation agreement and signed consent form
- Affiliation to a health insurance system
Exclusion
- Confounding factor of renal inflammation: acute or recurrent pyelonephritis, BK virus nephropathy
- Pregnant or breast-feeding women
- Persons under legal protection
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT07134491
Start Date
October 1 2025
End Date
October 1 2028
Last Update
August 21 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nephrology department, Hôpital Pitié Salpêtière
Paris, France, 75013
2
Nephrology department, Tenon hospital
Paris, France, 75020